Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
San-hu Gou, Miao He, Bei-bei Li, Ning-yi Zhu & Jing-man Ni. (2021) Hepatoprotective effect of total flavonoids from Glycyrrhiza uralensis Fisch in liver injury mice. Natural Product Research 35:24, pages 6083-6087.
Read now
Read now
Laura Draijer, Marc Benninga & Bart Koot. (2019) Pediatric NAFLD: an overview and recent developments in diagnostics and treatment. Expert Review of Gastroenterology & Hepatology 13:5, pages 447-461.
Read now
Read now
Articles from other publishers (20)
Kathrin Krüger, Carina Oedingen, Achim Kautz, Diane Langenbacher, Siegbert Rossol, Jona T. Stahmeyer & Christian Krauth. (2023) Lifestyle interventions for patients with non-alcoholic steato-hepatitis–Design, rationale and protocol of the study “target group-specific optimisation of lifestyle interventions for behavior change in non-alcoholic steato-hepatitis (OPTI-NASH)”. PLOS ONE 18:7, pages e0288905.
Crossref
Crossref
Xiaojuan Peng, Juan Li, Hailiang Zhao, Junlong Lai, Junqin Lin & Shaohui Tang. (2022) Lifestyle as well as metabolic syndrome and non-alcoholic fatty liver disease: an umbrella review of evidence from observational studies and randomized controlled trials. BMC Endocrine Disorders 22:1.
Crossref
Crossref
Aqib B. Chowdhury & Kosha J. Mehta. (2022) Liver biopsy for assessment of chronic liver diseases: a synopsis. Clinical and Experimental Medicine 23:2, pages 273-285.
Crossref
Crossref
Cong Yin, Zihan Li, Yulin Xiang, Hongbing Peng, Ping Yang, Shijun Yuan, Xueyan Zhang, You Wu, Min Huang & Juan Li. (2021) Effect of Intermittent Fasting on Non-Alcoholic Fatty Liver Disease: Systematic Review and Meta-Analysis. Frontiers in Nutrition 8.
Crossref
Crossref
Cara Reiter-Brennan, Omar Dzaye, Dorothy Davis, Mike Blaha & Robert H. Eckel. (2021) Comprehensive Care Models for Cardiometabolic Disease. Current Cardiology Reports 23:3.
Crossref
Crossref
Simona Cernea & Itamar Raz. (2020)
NAFLD
in type 2 diabetes mellitus: Still many challenging questions
. Diabetes/Metabolism Research and Reviews 37:2.
Crossref
Crossref
M. A. Livzan, O. V. Gaus, N. A. Nikolaev & T. S. Krolevetz. (2020) NAFLD: comorbidity and associated diseases. Experimental and Clinical Gastroenterology 1:10, pages 57-65.
Crossref
Crossref
Liang Liu, Ping Li, Yiqi Liu & Yilian Zhang. (2019) Efficacy of Probiotics and Synbiotics in Patients with Nonalcoholic Fatty Liver Disease: A Meta-Analysis. Digestive Diseases and Sciences 64:12, pages 3402-3412.
Crossref
Crossref
David Houghton, Paweł Zalewski, Kate Hallsworth, Sophie Cassidy, Christian Thoma, Leah Avery, Joanna Slomko, Timothy Hardy, Alastair D. Burt, Dina Tiniakos, Kieren G. Hollingsworth, Roy Taylor, Christopher P. Day, Steven Masson, Stuart McPherson, Quentin M. Anstee, Julia L. Newton & Michael I. Trenell. (2019) The degree of hepatic steatosis associates with impaired cardiac and autonomic function. Journal of Hepatology 70:6, pages 1203-1213.
Crossref
Crossref
Filippo Procino, Giovanni Misciagna, Nicola Veronese, Maria G. Caruso, Marisa Chiloiro, Anna M. Cisternino, Maria Notarnicola, Caterina Bonfiglio, Irene Bruno, Claudia Buongiorno, Angelo Campanella, Valentina Deflorio, Isabella Franco, Rocco Guerra, Carla M. Leone, Antonella Mirizzi, Alessandro Nitti & Alberto R. Osella. (2019) Reducing NAFLD-screening time: A comparative study of eight diagnostic methods offering an alternative to ultrasound scans. Liver International 39:1, pages 187-196.
Crossref
Crossref
Praveena Narayanan, Kristin Mara, Manhal Izzy, Ross Dierkhising, Julie Heimbach, Alina M. Allen & Kymberly D. Watt. (2019) Recurrent or De Novo Allograft Steatosis and Long-term Outcomes After Liver Transplantation. Transplantation 103:1, pages e14-e21.
Crossref
Crossref
Antonino Tuttolomondo, Salvatore Petta, Alessandra Casuccio, Carlo Maida, Vittoriano Della Corte, Mario Daidone, Domenico Di Raimondo, Rosaria Pecoraro, Roberto Fonte, Anna Cirrincione, Rita Zafonte, Daniela Cabibi, Calogero Cammà, Vito Di Marco, Anna Licata, Franco Magliozzo, Giulio Marchesini, Giovanni Merlino, Antonio Craxì & Antonio Pinto. (2018) Reactive hyperemia index (RHI) and cognitive performance indexes are associated with histologic markers of liver disease in subjects with non-alcoholic fatty liver disease (NAFLD): a case control study. Cardiovascular Diabetology 17:1.
Crossref
Crossref
Christina N. Katsagoni, George V. Papatheodoridis, Panagiota Ioannidou, Melanie Deutsch, Alexandra Alexopoulou, Nikolaos Papadopoulos, Maria-Vasiliki Papageorgiou, Elizabeth Fragopoulou & Meropi D. Kontogianni. (2018) Improvements in clinical characteristics of patients with non-alcoholic fatty liver disease, after an intervention based on the Mediterranean lifestyle: a randomised controlled clinical trial. British Journal of Nutrition 120:2, pages 164-175.
Crossref
Crossref
Tian-Tian Zou, Chao Zhang, Yi-Fan Zhou, Yi-Jing Han, Jiao-Jiao Xiong, Xi-Xi Wu, Yong-Ping Chen & Ming-Hua Zheng. (2018) Lifestyle interventions for patients with nonalcoholic fatty liver disease: a network meta-analysis. European Journal of Gastroenterology & Hepatology 30:7, pages 747-755.
Crossref
Crossref
Praveen Kumar Conjeevaram Selvakumar, Mohammad Nasser Kabbany, Valerio Nobili & Naim Alkhouri. (2017) Nonalcoholic Fatty Liver Disease in Children. Pediatric Clinics of North America 64:3, pages 659-675.
Crossref
Crossref
Christina N. KatsagoniMichael GeorgoulisGeorge V. PapatheodoridisElisabeth FragopoulouPanagiota IoannidouMariviki PapageorgiouAlexandra AlexopoulouNikolaos PapadopoulosMelanie DeutschMeropi D. Kontogianni. (2017) Associations Between Lifestyle Characteristics and the Presence of Nonalcoholic Fatty Liver Disease: A Case–Control Study. Metabolic Syndrome and Related Disorders 15:2, pages 72-79.
Crossref
Crossref
Christina N Katsagoni, Michael Georgoulis, George V Papatheodoridis, Demosthenes B Panagiotakos & Meropi D Kontogianni. (2017) Effects of lifestyle interventions on clinical characteristics of patients with non-alcoholic fatty liver disease: A meta-analysis. Metabolism 68, pages 119-132.
Crossref
Crossref
Daniela Gabbia, Stefano Dall’Acqua, Iole Di Gangi, Sara Bogialli, Valentina Caputi, Laura Albertoni, Ilaria Marsilio, Nicola Paccagnella, Maria Carrara, Maria Giron & Sara De Martin. (2017) The Phytocomplex from Fucus vesiculosus and Ascophyllum nodosum Controls Postprandial Plasma Glucose Levels: An In Vitro and In Vivo Study in a Mouse Model of NASH. Marine Drugs 15:2, pages 41.
Crossref
Crossref
Brendan Campbell, Maria Aguilar, Taft Bhuket, Sharon Torres, Benny Liu & Robert J. Wong. (2016) Females, Hispanics and older individuals are at greatest risk of developing metabolic syndrome in the U.S.. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 10:4, pages 230-233.
Crossref
Crossref
Lisa B. VanWagner & Mary E. Rinella. (2016) Extrahepatic Manifestations of Nonalcoholic Fatty Liver Disease. Current Hepatology Reports 15:2, pages 75-85.
Crossref
Crossref